Co-Authors
This is a "connection" page, showing publications co-authored by Brandon Henry and Gian Salvagno.
Connection Strength
1.966
-
Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine. J Occup Environ Med. 2021 11 01; 63(11):e829.
Score: 0.244
-
The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay. Int J Infect Dis. 2021 Oct; 111:65-67.
Score: 0.241
-
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals. Diagnosis (Berl). 2021 08 18; 9(1):146-148.
Score: 0.241
-
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers. J Infect. 2021 08; 83(2):e4-e5.
Score: 0.238
-
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay. EJIFCC. 2021 Jun; 32(2):216-223.
Score: 0.238
-
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay. Clin Chem Lab Med. 2021 09 27; 59(10):e377-e379.
Score: 0.238
-
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination. Diagnostics (Basel). 2021 May 04; 11(5).
Score: 0.236
-
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Diagnosis (Berl). 2021 08 26; 8(3):322-326.
Score: 0.231
-
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series. Clin Chem Lab Med. 2021 Aug 26; 59(9):1585-1591.
Score: 0.059